Sign In

Antiretroviral Therapy.

HIV Question Bank

Drug Interactions with Antiretroviral MedicationsQuestion 5/10

Questions in Topic

A 45-year-old cisgender man with HIV and genotype 1b hepatitis C virus (HCV) infection is taking dolutegravir plus darunavir-cobicistat-tenofovir alafenamide-emtricitabine. He consistently has undetectable HIV RNA levels and a recent CD4 count was 393 cells/mm3. A FibroScan performed 6 weeks prior showed evidence of cirrhosis. The plan is to start hepatitis C treatment with glecaprevir-pibrentasvir.

Which one of the following should you be most concerned about from a potential drug interaction standpoint?

Prev  Skip

Sign In or Register Progress Not Saved!
Since you are not signed in, your progress won't be saved.
Question Last Updated
August 28th, 2024

Steps to Acquire CE for this Question Bank Topic:

1

Answer

Answer all questions
2

Score 80%+

Answer correctly
3

Claim CE

Choose CNE or CME
4

Give Feedback

Complete survey
5

Print Certificate

Obtain proof of CE

This question requires improvement because:


Comment further on how to improve this question or summary:



Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.